Insider · CIK 0001400971

Campbell Bradley L

Reports to the SEC for 3 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001400971

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−188K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−266K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−284K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−301K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−104K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−1.01M sh	$14.50	−$14.6M	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−152K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−188K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−483K sh	—	—	0
2026-03-02	AMICUS THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−22.5K sh	$14.35	−$323K	998,680
2026-01-20	AMICUS THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−75K sh	$14.31	−$1.07M	1,021,180
2026-01-20	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−75K sh	—	—	0
2026-01-20	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+75K sh	$6.10	+$458K	1,096,180
2025-12-26	AMICUS THERAPEUTICS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−109K sh	$14.25	−$1.55M	1,021,180
2025-12-15	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−70.4K sh	—	—	0
2025-12-15	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+70.4K sh	$9.03	+$636K	1,207,708
2025-12-15	AMICUS THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−77.9K sh	$10.86	−$846K	1,129,782
2025-12-01	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−14.6K sh	—	—	70,426
2025-12-01	AMICUS THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−14.6K sh	$10.01	−$146K	1,137,282
2025-12-01	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14.6K sh	$9.03	+$132K	1,151,869
2025-11-24	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14.6K sh	$9.03	+$132K	1,151,869
2025-11-24	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−14.6K sh	—	—	85,013
2025-11-24	AMICUS THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−14.6K sh	$10.04	−$147K	1,137,282
2025-03-15	AMICUS THERAPEUTICS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−13.4K sh	$8.90	−$119K	1,137,282
2025-02-19	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−400 sh	—	—	99,600
2025-02-19	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+400 sh	$9.03	+$3,612	1,151,057
2025-02-19	AMICUS THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−400 sh	$10.00	−$4,000	1,150,657
2025-02-11	AMICUS THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+137K sh	—	—	1,220,768
2025-02-11	AMICUS THERAPEUTICS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−70.7K sh	$9.57	−$677K	1,150,657
2025-01-04	AMICUS THERAPEUTICS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−7,368 sh	$9.41	−$69.3K	1,083,693
2025-01-03	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Director, President and CEO	AAward	+483K sh	—	—	482,908
2025-01-03	AMICUS THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+267K sh	—	—	1,132,535
2025-01-03	AMICUS THERAPEUTICS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−41.5K sh	$9.41	−$390K	1,091,061
2025-01-02	AMICUS THERAPEUTICS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−20.6K sh	$9.31	−$192K	866,007
2024-12-02	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,500 sh	—	—	0
2024-12-02	AMICUS THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−7,500 sh	$10.02	−$75.1K	886,654
2024-12-02	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,500 sh	$8.61	+$64.6K	894,154
2024-11-06	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,901 sh	—	—	67,100
2024-11-06	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,901 sh	$12.28	+$97K	894,555
2024-11-06	AMICUS THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−7,901 sh	$12.50	−$98.8K	886,654
2024-11-01	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,500 sh	—	—	7,500
2024-11-01	AMICUS THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−7,500 sh	$11.46	−$86K	886,654
2024-11-01	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,500 sh	$8.61	+$64.6K	894,154
2024-10-01	AMICUS THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−7,500 sh	$10.60	−$79.5K	886,654
2024-10-01	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,500 sh	$8.61	+$64.6K	894,154
2024-10-01	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,500 sh	—	—	15,000
2024-09-03	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,500 sh	—	—	22,500
2024-09-03	AMICUS THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−7,500 sh	$11.71	−$87.8K	886,654
2024-09-03	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,500 sh	$8.61	+$64.6K	894,154
2024-08-01	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,500 sh	—	—	30,000

Recent filings

Accepted (ET)
Apr 274
Campbell Bradley L0001193125-26-182241
SEC(opens sec.gov)
Mar 44
Campbell Bradley L0001193125-26-092114
SEC(opens sec.gov)
Jan 224
Campbell Bradley L0001193125-26-019838
SEC(opens sec.gov)
Dec 304
Campbell Bradley L0001193125-25-337338
SEC(opens sec.gov)
Dec 174
Campbell Bradley L0001193125-25-323151
SEC(opens sec.gov)
Dec 34
Campbell Bradley L0001193125-25-307200
SEC(opens sec.gov)

Companies

Address

47 HULFISH STREET

PRINCETON, NJ, 08542